BSPM [Biostar Pharmaceuticals,] 8-K: (Original Filing)

[] [Biostar Pharmaceuticals to Host Virtual Presentation February 18th at 10:30 AM EST XIANYANG, China, Feb. 17, 2011 -- Biostar Pharmaceuticals, Inc. (Nasdaq: BSPM) ("Biostar" or "the Company"), Xianyang, PRC-based manufacturer of an over-the-counter Hepatitis B medicine, Xin Aoxing Oleanolic Acid Capsules, and a variety of other pharmaceutical products in the PRC, today announced that Bill Chen, CFO, will host a]

By | 2016-03-03T13:20:10+00:00 February 18th, 2011|Categories: BSPM, Chinese Stocks, SEC Original|Tags: , , , , , |0 Comments

BSPM [Biostar Pharmaceuticals,] 8-K: (Original Filing)

[ex99-1.htm 2 EX-99.1] [Biostar Pharmaceuticals to Host Virtual Presentation February 18th at 10:30 AM EST XIANYANG, China, Feb. 17, 2011 -- Biostar Pharmaceuticals, (Nasdaq: BSPM) ("Biostar" or "thempany"), Xianyang,-based manufacturer of an over-the-counter Hepatitis B medicine, Xin Aoxing Oleanolic Acidpsules, and a variety of other pharmaceutical products in the today announced that Bill Chen, CFO, will host a]

By | 2016-02-07T16:29:40+00:00 February 18th, 2011|Categories: BSPM, Chinese Stocks, SEC Original|Tags: , , , , , |0 Comments

CPHI [CHINA PHARMAS,] SC 13G: (Original Filing)

[for a reporting persons initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be filed for the purpose (Act) or otherwise subject to]

By | 2016-03-03T19:54:39+00:00 February 16th, 2011|Categories: Chinese Stocks, CPHI, SEC Original|Tags: , , , , , |0 Comments

CPHI [CHINA PHARMAS,] SC 13G: for a reporting persons initial filing on this

[for a reporting persons initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be filed for the purpose (Act) or otherwise subject to]

By | 2016-03-03T19:55:53+00:00 February 16th, 2011|Categories: Chinese Stocks, CPHI, Webplus ver|Tags: , , , , , |0 Comments

CPHI [CHINA PHARMAS,] SC 13G: (Original Filing)

[1. Names of Reporting Persons. Popeset Management, I.R.S. Identification Nos. ofove persons 62-1871308 2. Check the Appropriate Box if a Member of a (a) (b) 3. SEC Use Only 4. Citizenship or Place of Organization Tennessee Number of Shares Beneficially Owned by Each Reporting Person With 5. Sole Voting Power 2,248,533* 6. Shared Voting Power]

By | 2016-02-07T23:11:33+00:00 February 16th, 2011|Categories: Chinese Stocks, CPHI, SEC Original|Tags: , , , , , |0 Comments

CPHI [CHINA PHARMAS,] SC 13G: 1. Names of Reporting Persons. Popeset Management, I.R.S.

[1. Names of Reporting Persons. Popeset Management, I.R.S. Identification Nos. ofove persons 62-1871308 2. Check the Appropriate Box if a Member of a (a) (b) 3. SEC Use Only 4. Citizenship or Place of Organization Tennessee Number of Shares Beneficially Owned by Each Reporting Person With 5. Sole Voting Power 2,248,533* 6. Shared Voting Power]

By | 2016-02-07T23:12:26+00:00 February 16th, 2011|Categories: Chinese Stocks, CPHI, Webplus ver|Tags: , , , , , |0 Comments

TPI [TIANYIN PHARMACEUTICAL] SC 13G: (Original Filing)

[for a reporting persons initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be filed for the purpose (Act) or otherwise subject to]

By | 2016-03-27T21:28:03+00:00 February 16th, 2011|Categories: Chinese Stocks, SEC Original, TPI|Tags: , , , , , |0 Comments

TPI [TIANYIN PHARMACEUTICAL] SC 13G: for a reporting persons initial filing on this

[for a reporting persons initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be filed for the purpose (Act) or otherwise subject to]

By | 2016-03-27T21:28:56+00:00 February 16th, 2011|Categories: Chinese Stocks, TPI, Webplus ver|Tags: , , , , , |0 Comments
Skip to toolbar